Adial Pharmaceuticals, Inc.

About

Adial is focused on developing therapies for the treatment and prevention of addiction and related disorders. Our lead investigational drug candidate, AD04, is a genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder (AUD).

Contact

Dick Leary

Phone Number

(434) 422-9800

Sector

Therapeutics

Company Stage

Development

Funding Sources

  • Grants
  • Private Investment
  • Publicly Traded

Company Size

9

Facility Size

4200 sq ft

Address

1180 Seminole Trail
Charlottesville, VA 22901

Related News